NEUP Neuphoria Therapeutics Inc.: institutional ownership and insider trading

22 funds reported holding $8.68M of Neuphoria Therapeutics Inc. in their latest 13F filings; in Q2 2026 funds net bought $1.61M, with 8 new positions and 3 funds selling out; over the last 12 months insiders bought $0 and sold $0 on the open market.

NEUP revenue and earnings

• Quarter ended Mar 31, 2026: revenue n/a, net income −$505K, EPS -0.09
• Quarter ended Dec 31, 2025: revenue n/a, net income $1.86M, EPS -0.77
• Quarter ended Sep 30, 2025: revenue n/a, net income −$9.91M, EPS -4.41
• Quarter ended Jun 30, 2025: revenue n/a, net income −$8.88M, EPS -4.37

Famous investors holding NEUP

• Ken Griffin (Citadel Advisors): $317K, 0.0% of the portfolio
• Renaissance Technologies (Renaissance Technologies): $111K, 0.0% of the portfolio

Largest institutional holders of NEUP

1. Lynx1 Capital Management LP — $3.83M
2. AdvisorShares Investments LLC — $1.11M
3. VANGUARD CAPITAL MANAGEMENT LLC — $758K
4. Shay Capital LLC — $681K
5. BALYASNY ASSET MANAGEMENT L.P. — $622K
6. CITADEL ADVISORS LLC — $317K
7. GEODE CAPITAL MANAGEMENT, LLC — $216K
8. Ikarian Capital, LLC — $207K
9. VANGUARD FIDUCIARY TRUST CO — $148K
10. ADAR1 Capital Management, LLC — $131K

Recent NEUP insider trades

• Oct 21, 2025: Nichols Weston bought 639,110 shares ($3.29M)

5%+ owners

• AdvisorShares Trust: 5.8% (Schedule 13G, filed Oct 5, 2026)

All NEUP 13F holders · All NEUP insider trades